Drug: COPAXONE Injury: Injection site erythema Quarter: 2016Q3
Total Records: 58 Number of Pages: 3
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
127569961 | COPAXONE | Injection site erythema | TEVA | 0.00 | 0 | 20160918 | US | |
127570241 | COPAXONE | Injection site erythema | TEVA | 0.00 | F | 0 | 20160918 | US |
127618461 | COPAXONE | Injection site erythema | TEVA | 0.00 | F | 0 | 20160920 | US |
127627171 | COPAXONE | Injection site erythema | TEVA | 29.00 YR | F | 0 | 20160920 | US |
127628511 | COPAXONE | Injection site erythema | FDA-CTU | 54.00 YR | F | 0 | 20160915 | US |
127650051 | COPAXONE | Injection site erythema | TEVA | 49.00 YR | F | 0 | 20160921 | US |
127651521 | COPAXONE | Injection site erythema | TEVA | 48.77 YR | M | 0 | 20160921 | US |
127651971 | COPAXONE | Injection site erythema | TEVA | 0.00 | M | 0 | 20160921 | US |
127700081 | COPAXONE | Injection site erythema | TEVA | 0.00 | M | 0 | 20160922 | US |
127740561 | COPAXONE | Injection site erythema | TEVA | 52.74 YR | F | 0 | 20160923 | US |
127740591 | COPAXONE | Injection site erythema | TEVA | 65.22 YR | F | 0 | 20160923 | US |
127749371 | COPAXONE | Injection site erythema | FDA-CTU | 53.00 YR | F | 0 | 20160921 | US |
127813461 | COPAXONE | Injection site erythema | TEVA | 31.75 YR | F | 85 KG | 20160926 | US |
127909451 | COPAXONE | Injection site erythema | TEVA | 42.90 YR | F | 0 | 20160929 | US |
127918691 | COPAXONE | Injection site erythema | TEVA | 0.00 | F | 0 | 20160929 | US |
127957331 | COPAXONE | Injection site erythema | TEVA | 0.00 | F | 0 | 20160929 | US |
127975431 | COPAXONE | Injection site erythema | FDA-CTU | 52.00 YR | F | 0 | 20160929 | US |
127990501 | COPAXONE | Injection site erythema | TEVA | 0.00 | M | 0 | 20160930 | US |
Total Records: 58 Number of Pages: 3